Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9605)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 15, 2016 (publication date) through Oct 31, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Murillo Ortíz B, Ramírez Emiliano J, Ramos-Rodríguez E, Martínez-Garza S, Macías-Cervantes H, Solorio-Meza S, Pereyra-Nobara TA. Brain-derived neurotrophic factor plasma levels and premature cognitive impairment/dementia in type 2 diabetes. World J Diabetes 2016; 7(20): 615-620 [PMID: 28031779 DOI: 10.4239/wjd.v7.i20.615] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v7/i20/615.htm |
| Number | Citing Articles |
| 1 |
Natasha Z. Anita, Julia Zebarth, Brian Chan, Che-Yuan Wu, Taha Syed, Dinie Shahrul, Michelle M. Nguyen, Maureen Pakosh, Nathan Herrmann, Krista L. Lanctôt, Walter Swardfager. Inflammatory markers in type 2 diabetes with vs. without cognitive impairment; a systematic review and meta-analysis. Brain, Behavior, and Immunity 2022; 100: 55 doi: 10.1016/j.bbi.2021.11.005
|
| 2 |
Wan-li He, Fei-xia Chang, Tao Wang, Bi-xia Sun, Rui-rong Chen, Lian-ping Zhao, Purvi Purohit. Serum brain-derived neurotrophic factor levels in type 2 diabetes mellitus patients and its association with cognitive impairment: A meta-analysis. PLOS ONE 2024; 19(4): e0297785 doi: 10.1371/journal.pone.0297785
|
| 3 |
Mackayla L. Nelson, Julia A. Pfeifer, Jordan P. Hickey, Andrila E. Collins, Bettina E. Kalisch. Exploring Rosiglitazone’s Potential to Treat Alzheimer’s Disease through the Modulation of Brain-Derived Neurotrophic Factor. Biology 2023; 12(7): 1042 doi: 10.3390/biology12071042
|
| 4 |
Betul Sumbul-Sekerci, Abdusselam Sekerci, Ozge Pasin, Ezgi Durmus, Zeynep Irem Yuksel-Salduz. Cognition and BDNF levels in prediabetes and diabetes: A mediation analysis of a cross-sectional study. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1120127
|
| 5 |
Karishma Naidoo, Andile Khathi. The Potential Role of Gossypetin in the Treatment of Diabetes Mellitus and Its Associated Complications: A Review. International Journal of Molecular Sciences 2023; 24(24): 17609 doi: 10.3390/ijms242417609
|
| 6 |
Xue Zhao, Qing Han, You Lv, Lin Sun, Xiaokun Gang, Guixia Wang. Biomarkers for cognitive decline in patients with diabetes mellitus: evidence from clinical studies. Oncotarget 2018; 9(7): 7710 doi: 10.18632/oncotarget.23284
|
| 7 |
Oh Yoen Kim, Juhyun Song. The importance of BDNF and RAGE in diabetes-induced dementia. Pharmacological Research 2020; 160: 105083 doi: 10.1016/j.phrs.2020.105083
|
| 8 |
Kamila Wala-Zielińska, Karolina Świerczyńska-Mróz, Piotr K. Krajewski, Danuta Nowicka-Suszko, Magdalena Krajewska, Jacek C. Szepietowski. Elevated Level of Serum Neurotrophin-4, but Not of Brain-Derived Neurotrophic Factor, in Patients with Chronic Kidney Disease-Associated Pruritus. Journal of Clinical Medicine 2022; 11(21): 6292 doi: 10.3390/jcm11216292
|
| 9 |
Raziel Alejandro Arias-Sánchez, Luz Torner, Bertha Fenton Navarro. Polyphenols and Neurodegenerative Diseases: Potential Effects and Mechanisms of Neuroprotection. Molecules 2023; 28(14): 5415 doi: 10.3390/molecules28145415
|
| 10 |
YU.V. BYKOV, A.A. MURAVYOVA. LABORATORY BIOMARKERS FOR BRAIN DAMAGE IN DIABETES MELLITUS. AVICENNA BULLETIN 2023; 25(3): 370 doi: 10.25005/2074-0581-2023-25-3-370-379
|
| 11 |
Anna Quialheiro, Franciane Bobinski, Jéssica de Godoy Haefliger, Renata Del Antonio, Elisa Flores Lins, Daniel Fernandes Martins, Eleonora d’Orsi, André Junqueira Xavier, Marco Aurélio Peres. A comprehensive program of cognitive stimulation with digital inclusion, physical activity and social interaction can modify BDNF levels and improve cognition in adults over 50: a randomized controlled pilot study. Aging & Mental Health 2022; 26(10): 1979 doi: 10.1080/13607863.2021.1966742
|
| 12 |
Neyla S. Al-Akl, Olfa Khalifa, Georgios Ponirakis, Aijaz Parray, Marwan Ramadan, Shafi Khan, Mani Chandran, Raheem Ayadathil, Ahmed Elsotouhy, Ahmed Own, Hanadi Al Hamad, Julie Decock, Nehad M. Alajez, Omar Albagha, Rayaz A. Malik, Omar M. A. El-Agnaf, Abdelilah Arredouani. Untargeted Metabolomic Profiling Reveals Differentially Expressed Serum Metabolites and Pathways in Type 2 Diabetes Patients with and without Cognitive Decline: A Cross-Sectional Study. International Journal of Molecular Sciences 2024; 25(4): 2247 doi: 10.3390/ijms25042247
|
| 13 |
Aline Pertile Remor, Rodrigo Augusto da Silva, Filipe José de Matos, Viviane Glaser, Roberta de Paula Martins, Karina Ghisoni, Débora da Luz Scheffer, Denise Carleto Andia, Daniele Portinho, Ana Paula de Souza, Paulo Alexandre de Oliveira, Rui Daniel Prediger, Alicia I. Torres, Rose Marie Mueller Linhares, Roger Walz, Marcelo Fernando Ronsoni, Alexandre Hohl, Alex Rafacho, Aderbal Silva Aguiar, Ana Lucia De Paul, Alexandra Latini. Chronic Metabolic Derangement-Induced Cognitive Deficits and Neurotoxicity Are Associated with REST Inactivation. Molecular Neurobiology 2019; 56(3): 1539 doi: 10.1007/s12035-018-1175-9
|
| 14 |
R. L. Shyma, S. Mini. Neuroprotective effect of Morin via TrkB/Akt pathway against diabetes mediated oxidative stress and apoptosis in neuronal cells. Toxicology Mechanisms and Methods 2022; 32(9): 695 doi: 10.1080/15376516.2022.2065225
|
| 15 |
Milad Davarpanah, Nafiseh Shokri-mashhadi, Rahele Ziaei, Parvane Saneei. A systematic review and meta-analysis of association between brain-derived neurotrophic factor and type 2 diabetes and glycemic profile. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-93271-z
|
| 16 |
Mohamed El Oirdi. Harnessing the Power of Polyphenols: A New Frontier in Disease Prevention and Therapy. Pharmaceuticals 2024; 17(6): 692 doi: 10.3390/ph17060692
|
| 17 |
Yan-Feng Zhen, Xing-Yu Liu, Dong-Hao Zhou, Xiangdong Du, Guangzhong Yin, Yingyang Zhang, Hui Fang, Gang Xu, Jair C. Soares, Xiang Yang Zhang. Cognition, serum BDNF levels, and BDNF Val66Met polymorphism in type 2 diabetes patients and healthy controls. Oncotarget 2018; 9(3): 3653 doi: 10.18632/oncotarget.23342
|
| 18 |
Chen Zhang, Xinyu Fang, Peifen Yao, Yemeng Mao, Jun Cai, Yi Zhang, Meijuan Chen, Weixing Fan, Wei Tang, Lisheng Song. Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha. Psychoneuroendocrinology 2017; 81: 138 doi: 10.1016/j.psyneuen.2017.04.014
|
| 19 |
Ye Yang, Yi Liu, Guodong Wang, Gangrui Hei, Xiaoyi Wang, Ranran Li, Li Li, Renrong Wu, Jingping Zhao. Brain-derived neurotrophic factor is associated with cognitive impairments in first-episode and chronic schizophrenia. Psychiatry Research 2019; 273: 528 doi: 10.1016/j.psychres.2019.01.051
|
| 20 |
Tingting Liu, Lindsey Hettish, Wen‐Juo Lo, Michelle Gray, Changwei Li. FEASibility testing a randomized controlled trial of an exercise program to improve cognition for T2DM patients (the FEAST trial): A study protocol. Research in Nursing & Health 2021; 44(5): 746 doi: 10.1002/nur.22174
|
| 21 |
Yanyan Li, Feng Xu, Hanyan Xiao, Feng Han. Long noncoding RNA BDNF‐AS inversely regulated BDNF and modulated high‐glucose induced apoptosis in human retinal pigment epithelial cells. Journal of Cellular Biochemistry 2018; 119(1): 817 doi: 10.1002/jcb.26245
|
| 22 |
Włodzimierz Mrówczyński. Health Benefits of Endurance Training: Implications of the Brain-Derived Neurotrophic Factor—A Systematic Review. Neural Plasticity 2019; 2019: 1 doi: 10.1155/2019/5413067
|
| 23 |
Fatemeh Moosaie, Soheil Mohammadi, Amene Saghazadeh, Fatemeh Dehghani Firouzabadi, Nima Rezaei, Kenji Hashimoto. Brain-derived neurotrophic factor in diabetes mellitus: A systematic review and meta-analysis. PLOS ONE 2023; 18(2): e0268816 doi: 10.1371/journal.pone.0268816
|
| 24 |
Hanan Ehtewish, Abdelilah Arredouani, Omar El-Agnaf. Diagnostic, Prognostic, and Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline. International Journal of Molecular Sciences 2022; 23(11): 6144 doi: 10.3390/ijms23116144
|
| 25 |
Xiao Zhang, Zhao Huang-Fu, Xing-Ying Lang, Pu Chun, Yan-Yan Chi, Xiao-Ying Yuan, Xu-Gang Wang. Pathological and cognitive changes in patients with type 2 diabetes mellitus and comorbid MCI and protective hypoglycemic therapies: a narrative review. Reviews in the Neurosciences 2019; 30(7): 757 doi: 10.1515/revneuro-2018-0083
|
| 26 |
Michael A. Kalwat, Zhimin Huang, Derk D. Binns, Kathleen McGlynn, Melanie H. Cobb. α2-Adrenergic Disruption of β Cell BDNF-TrkB Receptor Tyrosine Kinase Signaling. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.576396
|